3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
5
Thoracic
2
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Sarcoma
18
Osteosarcoma
7
Neoplasm Metastasis
6
Lymphoma, Non-Hodgkin
6
Glioma
6
Ependymoma
6
Carcinosarcoma
6
Rhabdomyosarcoma
5
Neuroblastoma
5
Medulloblastoma
5
Liposarcoma
5
Leiomyosarcoma
5
Central Nervous System Neoplasms
5
Neuroectodermal Tumors, Primitive, Peripheral
4
Lymphoma, Follicular
4
Histiocytosis, Langerhans-Cell
4
Histiocytoma, Malignant Fibrous
4
Gliosarcoma
4
Glioblastoma
4
Endometrial Neoplasms
4
Wilms Tumor
3
Sarcoma, Kaposi
3
Rhabdoid Tumor
3
Prostatic Neoplasms
3
Oligodendroglioma
3
Melanoma
3
Lymphoma, B-Cell, Marginal Zone
3
Lung Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hepatoblastoma
3
Interventions
Nivolumab
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
pembrolizumab
2
Ipilimumab
2
Immunoglobulin G
2
tislelizumab
1
temsirolimus
1
spartalizumab
1
sargramostim
1
regorafenib
1
pemigatinib
1
eribulin
1
cabozantinib
1
brivanib
1
avelumab
1
X-Rays
1
Valproic Acid
1
Sirolimus
1
Radiosurgery
1
Mifepristone
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Docetaxel
1
Disulfides
1
Cyclophosphamide
1
Cryosurgery
1
Colony-Stimulating Factors
1
Clinical Trials, Phase II as Topic
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Biopsy
×
Sarcoma
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled